LIKE US ON FACEBOOK
FOLLOW US ON TWITTER
Posted on September 19, 2014
The U.S. Food and Drug Administration has approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
Pain / Anesthetics News From Medical News Today
Want to receive our Journal by mail? Sign up here.